Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)
DBCAT004503Pharmacologic class
Inhibitors of CYP1A2 enzyme with no identified strength of inhibition. A DrugBank category of 144 drugs. 117 of them are approved.
- Also known as
- Cytochrome P-450 CYP1A2 Inhibitors (unknown strength) · Unclassified CYP1A2 inhibitors
- Drugs
- Abametapir
- Abemaciclib
- Abiraterone
- Albinterferon Alfa-2B
- Anastrozole
- Atazanavir
- Avasimibe
- Belumosudil
- Berberine
- Besifloxacin
- Black cohosh
- Bortezomib
- Brincidofovir
- Caffeine
- Cannabidiol
- Cannabinol
- Capmatinib
- Carbamazepine
- Cepeginterferon alfa-2B
- Chamazulene
- Cinnamon oil
- Cinoxacin
- Cobalt chloride
- Cryptotanshinone
- Curcumin sulfate
What you can answer from here — as of May 20, 2021
Which targets do Cytochrome P-450 CYP1A2 Inhibitors (strength unknown) share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account